Topiramate in migraine prevention: a double-blind, placebo-controlled study.
about
Topiramate for the prophylaxis of episodic migraine in adultsAnticonvulsant drugs for migraine prophylaxisPreventive pharmacologic treatments for episodic migraine in adultsEvidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache SocietyAnticonvulsant drugs for migraine prophylaxisEvidence-Based Treatments for Adults with MigraineBipolar disorder in womenProphylaxis of migraine headacheTopiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.Clinical pharmacology of topiramate in migraine prevention.Antiepileptics in migraine prophylaxis: an updated Cochrane review.Placebo response in the prophylaxis of migraine: a meta-analysis.Anticonvulsants in migraine prophylaxis: a Cochrane review.Meta-analysis of efficacy of topiramate in migraine prophylaxis.Therapies in development for the treatment of migraine.Emerging drugs in migraine treatment.Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls.New anticonvulsant medication uses in bipolar disorder.A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.Topiramate: the evidence for its therapeutic value in the prevention of migraine.Preventive treatment of migraine: effect on weight.Topiramate in migraine prevention.Uses of topiramate in the treatment of alcohol dependence.A pilot study of topiramate dosages for migraine prophylaxis in an Asian population.The treatment of migraine headaches in children and adolescentsNew drugs for migraineTopiramate for the treatment of epilepsy and other nervous system disorders.Topiramate for migraine prevention.The pharmacotherapy of chronic pain: a review.The pharmacological treatment options for pediatric migraine: an evidence-based appraisal.Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial.Topiramate prophylaxis and response to triptan treatment for acute migraine.Preventive agents for migraine: focus on the antiepileptic drugs.Phentermine and topiramate for the management of obesity: a review.Topiramate for migraine prophylaxis.Optimizing prophylactic treatment of migraine: Subtypes and patient matching.The pharmacological management of migraine, part 2: preventative therapy.Current and emerging treatment options for migraine and other primary headache disorders.A replication study of GWAS findings in migraine identifies association in a Swedish case-control sample.Efficacy and mechanism of anticonvulsant drugs in migraine.
P2860
Q24201849-C117D740-CE50-4F81-96B1-899248DBBA7BQ24246734-13C8835C-B3AD-4ED8-8024-6D01994A2FC2Q24630992-23B5C6A7-56BF-45E7-81C9-B6AFCD4552A8Q24633523-EE3939A6-60CD-44FC-9E4F-BADADA72CAE2Q26471986-45A76737-0C83-4D69-B113-4BBDB5318A1BQ26769968-759FA6FC-116E-45D7-B967-13F32B4D6CFBQ26795404-1CEC585C-3BCB-4EFA-9C8E-0D5C5967B5D5Q33794672-723B4395-5311-4182-8607-615576261BDCQ34180705-FDEABBF2-F251-45BC-9717-223BA07C1924Q34200361-7FD3DC69-151F-414A-8762-A8BEF22773FBQ34433318-DEB1FBFC-5592-4495-8CBA-F2633F7E916DQ34621702-04F8FE68-1FE5-42C8-8567-991577183B9FQ34775712-B5BDDED6-0F97-465E-A8B4-24051A0E9ADCQ34997936-1C9CFCC5-A041-445C-B738-D4C9D5098355Q35011915-43BCA1A7-D85D-487B-887E-CE553443345EQ35602660-7253BF31-0542-4CCE-BE52-4E6A9CDBC0ADQ35609281-3F5DA245-2154-4C1C-8690-D037865D7F03Q35673095-7A785FD9-F422-4D52-849B-34E382769239Q35690766-EE78A23D-F4EB-4167-BD0A-4963613B2362Q35876387-55526DC6-190F-492A-A56F-D0A669B6E3F2Q35987931-8B940E7B-7CE1-4FFD-8E92-C0DF3479EFDFQ36099519-D44748DE-5B98-4E68-89D2-4978CD1055C4Q36106838-E9346407-748D-454C-947E-AF31535E6D29Q36261182-41292905-18B0-4DD0-989C-58F35B47742CQ36290746-CD78D98B-5FCF-4C90-98A3-422C40C5125DQ36332611-FB52D4A2-0898-471D-BC33-8B344BFDED99Q36390841-7A061DFB-5F74-4854-BB67-09738EBAB463Q36407219-EC57304F-4A9E-4235-A84B-35DC368489F7Q36411163-990D6634-BC73-439F-B7EE-08A6FD97C7A9Q36428744-F48B2313-BFD1-4EEC-A0B9-01A29B942B96Q36504620-C4C165B8-B889-4E71-9DB8-C845F5A21FF9Q36623181-9E687A1F-DE74-4446-B029-17A92B039FCAQ36748706-341ACC8A-C0D1-4C94-9532-8B496E901B73Q36758207-2B81378F-B0AB-4A60-8FB6-44F55AFDAF10Q36979333-A640B040-DC89-4872-AF38-ACBCD21F627FQ37052803-E4E655DB-5637-4007-A13A-DC7BFF6DA5AAQ37313626-F064EE6F-9CC0-4833-8E72-4C2AC7B2FA8DQ37610198-60315870-E041-4D64-BAE6-4B4495A1EFC8Q37702729-22942E92-A711-4F73-A5BB-201EA3108623Q38185096-AE9FDEDD-C05A-42F8-AEB2-44B7ED9A5346
P2860
Topiramate in migraine prevention: a double-blind, placebo-controlled study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Topiramate in migraine prevention: a double-blind, placebo-controlled study.
@en
Topiramate in migraine prevention: a double-blind, placebo-controlled study.
@nl
type
label
Topiramate in migraine prevention: a double-blind, placebo-controlled study.
@en
Topiramate in migraine prevention: a double-blind, placebo-controlled study.
@nl
prefLabel
Topiramate in migraine prevention: a double-blind, placebo-controlled study.
@en
Topiramate in migraine prevention: a double-blind, placebo-controlled study.
@nl
P2093
P2860
P1433
P1476
Topiramate in migraine prevention: a double-blind, placebo-controlled study.
@en
P2093
P2860
P304
P356
10.1046/J.1526-4610.2001.01190.X
P577
2001-11-01T00:00:00Z